Johnson M A, Klinger H, Thompson G K. "一种的合成方法" [P]. US Patent, US 11082922 B2, 2024-12-16.
O'Brien P Q, Chen K W, Stevens L M. "Method for the Synthesis of 3-Chloro-1-[4-(pyrimidin-2-yl)piperazin-1-yl]propan-1-one" [P]. US Patent, US 9190985 B2, 2016-10-05.
发明人王建平,朱建伟,何建平. "A Process for Preparing High-Purity 3-Chloro-1-[4-(pyrimidin-2-yl)piperazin-1-yl]propan-1-one" [P]. 中国发明专利, 专利号 CN 111359851 A, 授权公告日 2018-04-25.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2022, 419, (9), 7973-8002.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2022, 2187, 5327-5344.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 3-Chloro-1-[4-(pyrimidin-2-yl)piperazin-1-yl]propan-1-one Using HRMS and NMR". Biomed. Chromatogr., 2020, 1853, (11), 1990-2007.